Gene · 4973
Papers4,129
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,129
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-Wide Expression Profiling and Networking Reveals an Imperative Role of IMF-Associated Novel CircRNAs as ceRNA in Pigs. | Cells | 2022 | 36078046 | PubTator, text mining | PubMed |
| Positive Association between Autoantibodies Against Oxidized LDL and HDL-C: A Novel Mechanism for HDL Cardioprotection? | Arq Bras Cardiol | 2022 | 36074481 | PubTator, text mining | PubMed |
| Nalidixic acid potentiates the antitumor activity in sorafenib-resistant hepatocellular carcinoma via the tumor immune microenvironment analysis. | Front Pharmacol | 2022 | 36071851 | PubTator, text mining | PubMed |
| Current Strategies and Potential Prospects for Nanoparticle-Mediated Treatment of Diabetic Nephropathy. | Diabetes Metab Syndr Obes | 2022 | 36068795 | PubTator, text mining | PubMed |
| Recent advances in molecular biology of metabolic syndrome pathophysiology: endothelial dysfunction as a potential therapeutic target. | J Diabetes Metab Disord | 2022 | 36065330 | PubTator, text mining | PubMed |
| Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease. | J Transl Med | 2022 | 36064568 | PubTator, text mining | PubMed |
| Effects of exogenous calcium on the drought response of the tea plant (Camellia sinensis (L.) Kuntze). | PeerJ | 2022 | 36061747 | PubTator, text mining | PubMed |
| Old is new again: emergence of thromboembolic complications in cancer patients on immunotherapy. | Thromb Res | 2022 | 36061419 | PubTator, text mining | PubMed |
| Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma. | Nat Med | 2022 | 36038629 | PubTator, text mining | PubMed |
| Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2022 | 36038262 | PubTator, text mining | PubMed |
| Current evidence on the role of lipid lowering drugs in the treatment of psoriasis. | Front Med (Lausanne) | 2022 | 36035406 | PubTator, text mining | PubMed |
| Phenotypic, functional, and metabolic heterogeneity of immune cells infiltrating non-small cell lung cancer. | Front Immunol | 2022 | 36032082 | PubTator, text mining | PubMed |
| Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy. | J Hematol Oncol | 2022 | 36031601 | PubTator, text mining | PubMed |
| Advances in the use of exosomes for the treatment of ALI/ARDS. | Front Immunol | 2022 | 36016948 | PubTator, text mining | PubMed |
| Refining the DC-targeting vaccination for preventing emerging infectious diseases. | Front Immunol | 2022 | 36016929 | PubTator, text mining | PubMed |
| Oxidised Low-Density Lipoprotein-Induced Platelet Hyperactivity-Receptors and Signalling Mechanisms. | Int J Mol Sci | 2022 | 36012465 | PubTator, text mining | PubMed |
| Gene-microRNA Network Analysis Identified Seven Hub Genes in Association with Progression and Prognosis in Non-Small Cell Lung Cancer. | Genes (Basel) | 2022 | 36011391 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Regulation of Lipoxygenase Pathways and Reverse Cholesterol Transport in Atherogenesis. | Genes (Basel) | 2022 | 36011386 | PubTator, text mining | PubMed |
| Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities. | Cancers (Basel) | 2022 | 36011021 | PubTator, text mining | PubMed |
| Hsp90: From Cellular to Organismal Proteostasis. | Cells | 2022 | 36010556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4973/papers?page=46